Views & Analysis VPAS: Achievement so far on objectives for the economy and i... In the third part of this series taking stock of
Views & Analysis VPAS: Achievements so far on affordability In the second part of this series taking stock of
Views & Analysis VPAS: Achievement so far on objectives for patients The UK has a voluntary agreement that was struck by the government and NHS England (now referred to as NHSE&I) with the Association of the British Pharmaceutical Industry (ABPI) in 2018
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
